With current knowledge exposing the increasing complexity of SphK/S1P/S1PR signaling and the dependency on this signaling pathway in different cancer cell types, it is apparent that further study is of importance to characterize the specificity of SphK isoforms in cancer tissues when seeking new diagnostic targets and therapeutic interventions. This evidence concerns the gene SPHK1 and cancer.